Details for New Drug Application (NDA): 020001
✉ Email this page to a colleague
NDA 020001 describes CAPEX, which is a drug marketed by Galderma Labs Lp and is included in one NDA. Additional details are available on the CAPEX profile page.
The generic ingredient in CAPEX is fluocinolone acetonide. There are twelve drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the fluocinolone acetonide profile page.
The generic ingredient in CAPEX is fluocinolone acetonide. There are twelve drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the fluocinolone acetonide profile page.
Summary for 020001
| Tradename: | CAPEX |
| Applicant: | Galderma Labs Lp |
| Ingredient: | fluocinolone acetonide |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 020001
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SHAMPOO;TOPICAL | Strength | 0.01% | ||||
| Approval Date: | Aug 27, 1990 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
